Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

A complicated path to the CRMO diagnosis - case of a 9 year old girl whose story comes full circle.

Świdrowska-Jaros J, Smolewska E.

BMC Musculoskelet Disord. 2019 Aug 31;20(1):392. doi: 10.1186/s12891-019-2776-9.

2.

Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland.

Stasiak A, Smolewska E.

Rheumatol Int. 2019 Jun;39(6):1069-1076. doi: 10.1007/s00296-019-04286-9. Epub 2019 Mar 22.

PMID:
30903369
3.

Serum Level of Soluble CD226 Receptor in Healthy Individuals is Highly Variable and Associated with Age.

Hogendorf A, Wyka K, Orczyk K, Smolewska E, Mlynarski W.

Iran J Immunol. 2019 Mar;16(1):92-95. doi: 10.22034/IJI.2019.39410. No abstract available.

4.

Tocilizumab in the treatment of systemic-onset juvenile idiopathic arthritis - single-centre experience.

Roszkiewicz J, Orczyk K, Smolewska E.

Reumatologia. 2018;56(5):279-284. doi: 10.5114/reum.2018.79497. Epub 2018 Oct 31.

5.
6.

Comparison of uveitis in the course of juvenile idiopathic arthritis with isolated uveitis in children - own experiences.

Zygmunt A, Lipińska J, Biernacka-Zielińska M, Lipiec E, Niwald A, Smolewska E.

Reumatologia. 2018;56(3):149-154. doi: 10.5114/reum.2018.76902. Epub 2018 Jun 30.

7.

Is it possible to predict a risk of osteoporosis in patients with juvenile idiopathic arthritis? A study of serum levels of bone turnover markers.

Janicka-Szczepaniak M, Orczyk K, Szymbor K, Chlebna-Sokół D, Smolewska E.

Acta Biochim Pol. 2018;65(2):297-302. doi: 10.18388/abp.2017_2561. Epub 2018 May 30.

8.

Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial.

Opoka-Winiarska V, Żuber Z, Alexeeva E, Chasnyk V, Nikishina I, Dębowska G, Smolewska E.

Clin Rheumatol. 2018 Jul;37(7):1807-1816. doi: 10.1007/s10067-018-4071-9. Epub 2018 Apr 13.

9.

The Polish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Rutkowska-Sak L, Smolewska E, Zygmunt A, Kwiatkowska M, Gazda A, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):315-321. doi: 10.1007/s00296-018-3966-8. Epub 2018 Apr 7.

10.

From fibrosis to diagnosis: a paediatric case of microscopic polyangiitis and review of the literature.

Roszkiewicz J, Smolewska E.

Rheumatol Int. 2018 Apr;38(4):683-687. doi: 10.1007/s00296-017-3923-y. Epub 2018 Jan 2. Review.

PMID:
29294176
11.

A fresh look at angiogenesis in juvenile idiopathic arthritis.

Świdrowska-Jaros J, Smolewska E.

Cent Eur J Immunol. 2018;43(3):325-330. doi: 10.5114/ceji.2018.80052. Epub 2018 Oct 30. Review.

12.

Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.

Ruperto N, Brunner HI, Zuber Z, Tzaribachev N, Kingsbury DJ, Foeldvari I, Horneff G, Smolewska E, Vehe RK, Hazra A, Wang R, Mebus CA, Alvey C, Lamba M, Krishnaswami S, Stock TC, Wang M, Suehiro R, Martini A, Lovell DJ; Pediatric Rheumatology International Trials Organization (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG).

Pediatr Rheumatol Online J. 2017 Dec 28;15(1):86. doi: 10.1186/s12969-017-0212-y.

13.

Are We Right to Consider Mesenchymal Stem Cells to Be a New Perspective for Patients with Juvenile Idiopathic Arthritis?

Orczyk K, Smolewska E.

Arch Immunol Ther Exp (Warsz). 2018 Aug;66(4):267-271. doi: 10.1007/s00005-017-0493-3. Epub 2017 Oct 13. Review.

PMID:
29027570
14.

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.

Brunner HI, Ruperto N, Tzaribachev N, Horneff G, Chasnyk VG, Panaviene V, Abud-Mendoza C, Reiff A, Alexeeva E, Rubio-Pérez N, Keltsev V, Kingsbury DJ, Del Rocio Maldonado Velázquez M, Nikishina I, Silverman ED, Joos R, Smolewska E, Bandeira M, Minden K, van Royen-Kerkhof A, Emminger W, Foeldvari I, Lauwerys BR, Sztajnbok F, Gilmer KE, Xu Z, Leu JH, Kim L, Lamberth SL, Loza MJ, Lovell DJ, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).

Ann Rheum Dis. 2018 Jan;77(1):21-29. doi: 10.1136/annrheumdis-2016-210456. Epub 2017 May 15.

15.

When a patient suspected with juvenile idiopathic arthritis turns out to be diagnosed with an infectious disease - a review of Lyme arthritis in children.

Orczyk K, Świdrowska-Jaros J, Smolewska E.

Pediatr Rheumatol Online J. 2017 May 8;15(1):35. doi: 10.1186/s12969-017-0166-0. Review.

16.

In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?

Roszkiewicz J, Smolewska E.

Curr Rheumatol Rep. 2017 Apr;19(4):19. doi: 10.1007/s11926-017-0646-8. Review.

PMID:
28361333
17.

Are we closer to personalized therapy in juvenile idiopathic arthritis?

Smolewska E.

Reumatologia. 2016;54(4):151-152. Epub 2016 Oct 5. No abstract available.

18.

Kaleidoscope of autoimmune diseases in HIV infection.

Roszkiewicz J, Smolewska E.

Rheumatol Int. 2016 Nov;36(11):1481-1491. Epub 2016 Aug 20. Review.

PMID:
27544391
19.

The paediatric rheumatologist and orphan disease - a story without happy ending.

Roszkiewicz J, Biernacka-Zielińska M, Smolewska E.

Reumatologia. 2016;54(3):141-5. doi: 10.5114/reum.2016.61216. Epub 2016 Jul 18.

20.

Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).

Lipinska J, Lipinska S, Kasielski M, Smolewska E.

Clin Rheumatol. 2016 Nov;35(11):2699-2706. Epub 2016 Jul 25.

PMID:
27457366
21.

Macrophages - silent enemies in juvenile idiopathic arthritis.

Świdrowska-Jaros J, Orczyk K, Smolewska E.

Postepy Hig Med Dosw (Online). 2016 Jul 6;70(0):743-50. doi: 10.5604/17322693.1208887. Review.

22.

Nailfold capillaroscopy assessment of microcirculation abnormalities and endothelial dysfunction in children with primary or secondary Raynaud syndrome.

Latuskiewicz-Potemska J, Chmura-Skirlinska A, Gurbiel RJ, Smolewska E.

Clin Rheumatol. 2016 Aug;35(8):1993-2001. doi: 10.1007/s10067-016-3340-8. Epub 2016 Jun 29.

PMID:
27357717
23.

Serum Angiogenesis Markers and Their Correlation with Ultrasound-Detected Synovitis in Juvenile Idiopathic Arthritis.

Świdrowska J, Smolewski P, Stańczyk J, Smolewska E.

J Immunol Res. 2015;2015:741457. doi: 10.1155/2015/741457. Epub 2015 May 4.

24.

Influence of biologic therapy on growth in children with chronic inflammatory connective tissue diseases.

Świdrowska J, Zygmunt A, Biernacka-Zielińska M, Stańczyk J, Smolewska E.

Reumatologia. 2015;53(1):14-20. doi: 10.5114/reum.2015.50552. Epub 2015 Apr 10.

25.

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.

Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D, Martini A, De Benedetti F; Paediatric Rheumatology International Trials Organisation PRINTO; Pediatric Rheumatology Collaborative Study Group (PRCSG).

Ann Rheum Dis. 2015 Jun;74(6):1110-7. doi: 10.1136/annrheumdis-2014-205351. Epub 2014 May 16.

26.

Reactive oxygen species and serum antioxidant defense in juvenile idiopathic arthritis.

Lipińska J, Lipińska S, Stańczyk J, Sarniak A, Przymińska vel Prymont A, Kasielski M, Smolewska E.

Clin Rheumatol. 2015 Mar;34(3):451-6. doi: 10.1007/s10067-014-2571-9. Epub 2014 Mar 22.

27.

Hematopoietic stem cell transplantation in children with autoimmune connective tissue diseases.

Witkowska M, Smolewska E, Smolewski P.

Arch Immunol Ther Exp (Warsz). 2014 Aug;62(4):319-27. doi: 10.1007/s00005-014-0279-9. Epub 2014 Mar 7. Review.

PMID:
24604327
28.

Imbalance of Th17 and T-regulatory cells in peripheral blood and synovial fluid in treatment naïve children with juvenile idiopathic arthritis.

Szymańska-Kałuża J, Cebula-Obrzut B, Smolewski P, Stanczyk J, Smolewska E.

Cent Eur J Immunol. 2014;39(1):71-6. doi: 10.5114/ceji.2014.42128. Epub 2014 Apr 17.

29.

Mixed connective tissue disease presenting with progressive scleroderma symptoms in a 10-year-old girl.

Latuśkiewicz-Potemska J, Zygmunt A, Biernacka-Zielińska M, Stańczyk J, Smolewska E.

Postepy Dermatol Alergol. 2013 Oct;30(5):329-36. doi: 10.5114/pdia.2013.38365. Epub 2013 Oct 30.

30.

Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report.

Biernacka-Zielinska M, Lipinska J, Szymanska-Kaluza J, Stanczyk J, Smolewska E.

J Med Case Rep. 2013 Aug 23;7:221. doi: 10.1186/1752-1947-7-221.

31.

Anticitrullinated protein antibodies and radiological progression in juvenile idiopathic arthritis.

Lipinska J, Brózik H, Stanczyk J, Smolewska E.

J Rheumatol. 2012 May;39(5):1078-87. doi: 10.3899/jrheum.110879. Epub 2012 Mar 1.

PMID:
22382337
32.

Takayasu's arteritis mimicking Kawasaki disease in 7-month-old infant, successfully treated with glucocorticosteroids and intravenous immunoglobulins.

Kierzkowska B, Lipińska J, Barańska D, Niewiadomska-Jarosik K, Biernacka-Zielińska M, Stańczyk J, Smolewska E.

Rheumatol Int. 2012 Nov;32(11):3655-9. doi: 10.1007/s00296-010-1518-y. Epub 2010 May 15.

PMID:
20473497
33.

Relationship between impaired apoptosis of lymphocytes and distribution of dendritic cells in peripheral blood and synovial fluid of children with juvenile idiopathic arthritis.

Smolewska E, Cebula B, Brózik H, Stańczyk J.

Arch Immunol Ther Exp (Warsz). 2008 Jul-Aug;56(4):283-9. doi: 10.1007/s00005-008-0030-5. Epub 2008 Jul 29.

34.

Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis.

Smolewska E, Stańczyk J, Brózik H, Biernacka-Zielińska M, Cebula B, Robak T, Smolewski P.

Ann Rheum Dis. 2008 Jun;67(6):762-8. Epub 2007 Oct 26.

PMID:
17965117
36.

[Diagnostic value of thermography and endothelin concentration in serum of children with Raynaud's Syndrome].

Biernacka-Zielinska M, Brozik H, Smolewska E, Mikinka M, Jakubowska T, Stanczyk J.

Med Wieku Rozwoj. 2005 Apr-Jun;9(2):213-22. Polish.

PMID:
16085962
37.

Regulation of peripheral blood and synovial fluid lymphocyte apoptosis in juvenile idiopathic arthritis.

Smolewska E, Brózik H, Smolewski P, Darzynkiewicz Z, Stańczyk J.

Scand J Rheumatol. 2004;33(1):7-12. Erratum in: Scand J Rheumatol. 2004;33(3):198.

PMID:
15124936
38.

Apoptosis of peripheral blood lymphocytes in patients with juvenile idiopathic arthritis.

Smolewska E, Brozik H, Smolewski P, Biernacka-Zielinska M, Darzynkiewicz Z, Stanczyk J.

Ann Rheum Dis. 2003 Aug;62(8):761-3. Erratum in: Ann Rheum Dis. 2003 Nov;62(11):1126.

Supplemental Content

Loading ...
Support Center